These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 18364150)
1. Transcatheter closure of perimembranous ventricular septal defects by a new Amplatzer membranous ventricular septal defect occluder: a single center study in Beijing. Hu HB; Jiang SL; Xu ZY; Huang LJ; Zhao SH; Zhen H Chin Med J (Engl); 2008 Mar; 121(6):573-6. PubMed ID: 18364150 [No Abstract] [Full Text] [Related]
2. Cardiac conduction disturbances seen after transcatheter device closure of muscular ventricular septal defects with the Amplatzer occluder. Robinson JD; Zimmerman FJ; De Loera O; Heitschmidt M; Hijazi ZM Am J Cardiol; 2006 Feb; 97(4):558-60. PubMed ID: 16461056 [TBL] [Abstract][Full Text] [Related]
7. [Transcatheter closure of postinfarction ventricular septal defects using Amplatzer devices]. Bialkowski J; Szkutnik M; Kusa J; Kalarus Z; Gasior M; Przybylski R; Banaszak P; Zembala M Rev Esp Cardiol; 2007 May; 60(5):548-51. PubMed ID: 17535768 [TBL] [Abstract][Full Text] [Related]
8. Late complete atriovenous block after percutaneous closure of a perimembranous ventricular septal defect. Butera G; Massimo C; Mario C Catheter Cardiovasc Interv; 2006 Jun; 67(6):938-41. PubMed ID: 16649234 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter device closure of intracristal ventricular septal defects. Gu M; You X; Zhao X; Zheng X; Qin YW Am J Cardiol; 2011 Jan; 107(1):110-3. PubMed ID: 21146697 [TBL] [Abstract][Full Text] [Related]
10. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system. Fischer G; Apostolopoulou SC; Rammos S; Schneider MB; Bjørnstad PG; Kramer HH Cardiol Young; 2007 Oct; 17(5):499-504. PubMed ID: 17634162 [TBL] [Abstract][Full Text] [Related]
11. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Kenny D; Morgan G; Bajwa A; Farrow C; Parry A; Caputo M; Tometzki A; Martin R Catheter Cardiovasc Interv; 2009 Mar; 73(4):568-75. PubMed ID: 19235245 [TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. Fu YC; Bass J; Amin Z; Radtke W; Cheatham JP; Hellenbrand WE; Balzer D; Cao QL; Hijazi ZM J Am Coll Cardiol; 2006 Jan; 47(2):319-25. PubMed ID: 16412854 [TBL] [Abstract][Full Text] [Related]
13. [Short- and mid-term outcomes of arrhythmia after transcatheter and surgical closure of membranous ventricular septal defects: a comparative analysis]. Zhu XY; Liu YH; Han XM; Hou CJ; Sheng XT; Zhang DZ; Cui CS; Deng DA Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2997-3000. PubMed ID: 18261335 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of iatrogenic perimembranous ventricular septal defect after aortic valve and ascending aorta replacement using an Amplatzer membranous ventricular septal occluder. Chojnicki M; Sukiennik A; Anisimowicz L; Swiatkiewicz I; Pawliszak W Cardiol J; 2008; 15(2):189-91. PubMed ID: 18651405 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous closure of post-traumatic and congenital muscular ventricular septal defects with the Amplatzer Muscular VSD Occluder. Szkutnik M; Kusa J; Białkowski J Kardiol Pol; 2008 Jul; 66(7):715-20; discussion 721. PubMed ID: 18690562 [TBL] [Abstract][Full Text] [Related]
16. Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder. Eicken A; Balling G; Gildein HP; Genz T; Kaemmerer H; Hess J Int J Cardiol; 2007 Apr; 117(1):e40-2. PubMed ID: 17196689 [TBL] [Abstract][Full Text] [Related]
17. Catheter closure of perimembranous/membranous ventricular septal defects using the Amplatzer occluder device. Thanopoulos BD Pediatr Cardiol; 2005; 26(4):311-4. PubMed ID: 16374677 [TBL] [Abstract][Full Text] [Related]
18. Comparison of results and complications of surgical and Amplatzer device closure of perimembranous ventricular septal defects. Xunmin C; Shisen J; Jianbin G; Haidong W; Lijun W Int J Cardiol; 2007 Aug; 120(1):28-31. PubMed ID: 17084470 [TBL] [Abstract][Full Text] [Related]
19. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: A single-center experience on 1046 cases. Bai Y; Xu XD; Li CY; Zhu JQ; Wu H; Chen SP; Chen F; You XH; Zhao XX; Qin YW Heart Rhythm; 2015 Oct; 12(10):2132-40. PubMed ID: 25981147 [TBL] [Abstract][Full Text] [Related]
20. Is steroid therapy enough to reverse complete atrioventricular block after percutaneous perimembranous ventricular septal defect closure? Butera G; Gaio G; Carminati M J Cardiovasc Med (Hagerstown); 2009 May; 10(5):412-4. PubMed ID: 19262403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]